. 02/2012: Yuanxin's epigenetic paper with Katrin Chua lab at Stanford was accepted to Nature. Two years of hard work finally paid off!
. 02/2012: Liguo Wang was offered a tenure-track Assistant Professor position at Mayo Clinic. Congratulations!
. 02/2012: Justin Park will join us as a Postdoc Associate. Justin will graduate in May with a PhD in Computer Science from Rice University. Welcome!
. 11/2011: Yuanxin's RRBSMAP paper was accepted to Bioinformatics.
. 09/2011: Wei Li was promoted to tenured Associate Professor at BCM. Cheers!
. 09/2011: Deqiang's DNA methylation paper with Peggy Goodell lab was accepted to Nature Genetics.
. 08/2011: Kaifu's NSD2 epigenetic paper with Or Gozani lab at Stanford was accepted to Molecular Cell.
. 08/2011: A NIH R01 grant was funded. We will work with Dr. Wang at the Ohio State University to understand the role of histone methylations in prostate cancer.
. 07/2011: Liguo's FoxA1 cistrome paper was accepted to Cancer Research.
. 07/2011: See our Genomic Regulation Technical Guide on Genome Technology magazine
. 07/2011: Dr. Zheng Xia will join us as a postdoc fellow. Zheng has PhD in Control Theory and Engineering Computer Science from Zhejiang University in China. Welcome!
. 05/2011: Dr.Bert O'Malley's coregulator network paper was published in Cell. Wei is a co-author on the paper.
. 04/2011: Yuanxin's epigenomic paper was invited for revision in Nature.
. 04/2011: Liguo's Prostate Cancer RNA-seq paper was officially accepted to PNAS.
. 03/2011: Our Texas CPRIT Multi-Investigator grant was funded with a total direct cost of ~$10M for 5 years. This project will bring together a "dream team" in cancer epigenetic research. We will direct the bioinformatics component for LONESTAR.
. 01/2011: Yuanxin's fragile nucleosome paper was accepted to Genome Research.
. 01/2011: Yuanxin and Liguo's Atoh1 targetome paper was accepted to PNAS.
. 12/2010: Liguo's fly RNA-seq paper was published in Genome Research.
. 10/2010: A Texas CPRIT grant was funded. We will work with Dr. Goodell at BCM to understand DNA Methylgransferase 3B in normal and malignant hematopoiesis.
. 08/2010: Our Pilot Project was funded by a NIH Stem Cell P01 Grant.
. 07/2010: The DNA methylation platform comparision paper was accepted to Nature Biotechnology.